Induction chemotherapy for oral cavity cancer patients: Current status and future perspectives
- 1 December 2015
- journal article
- review article
- Published by Elsevier in Oral Oncology
- Vol. 51 (12) , 1069-1075
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- State-of-the-Art and Emerging Treatment Options in the Management of Head and Neck Cancer: News from 2013Oncology, 2014
- Cancers de la cavité orale. Mise au point Sous l’égide de l’Intergroupe ORLBulletin du Cancer, 2014
- Intensity-modulated radiation therapy for head and neck cancer: Systematic review and meta-analysisRadiotherapy and Oncology, 2014
- Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative studyCancer, 2013
- Induction chemotherapy in head and neck cancerAnti-Cancer Drugs, 2011
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapyHead & Neck, 2009
- Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck CancerNew England Journal of Medicine, 2007
- Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerNew England Journal of Medicine, 2007
- Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck CancerJournal of Clinical Oncology, 2005